PubRank

V Agnello

Author PubWeight™ 90.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. Immunology 1970 6.89
2 Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels. Clin Exp Immunol 1970 5.10
3 Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med 1973 4.93
4 Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med 1971 4.62
5 Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration. J Exp Med 1971 2.75
6 Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 1971 2.64
7 C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 1971 2.43
8 Antibodies to polynucleotides: distribution in human serums. Science 1969 2.43
9 The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 1973 2.42
10 The joint-fluid gammaG-globulin complexes and their relationship to intraarticular complement dimunition. Ann N Y Acad Sci 1969 2.26
11 Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol 1974 2.12
12 Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus. Am J Pathol 1969 2.11
13 Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med 1980 2.10
14 Complement deficiency states. Medicine (Baltimore) 1978 2.08
15 Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol 1972 2.02
16 Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor. J Clin Invest 1977 1.96
17 Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate. Clin Exp Immunol 1969 1.88
18 Opsonic activity in human serum deficient in C2. J Immunol 1972 1.88
19 Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis. J Rheumatol 1991 1.65
20 Immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int 1973 1.55
21 Human rheumatoid factor cross-idiotypes. III. Bla monoclonal rheumatoid factor, prototype of the BLA cross-idiotype group, has distinct kappa chains related to the V kappa III subgroup and VH4 heavy chains. Arthritis Rheum 1990 1.43
22 Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 1979 1.20
23 Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988 1.17
24 Evidence for a silent or null gene in hereditary C2 deficiency. J Immunol 1978 1.12
25 Lupus diseases associated with hereditary and acquired deficiencies of complement. Springer Semin Immunopathol 1986 1.09
26 Human rheumatoid factor crossidiotypes. I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 1986 1.07
27 Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 1971 1.07
28 Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J Clin Microbiol 2000 1.00
29 Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds. J Exp Med 1993 0.99
30 Immune complex assays: the first ten years. Ann Intern Med 1981 0.98
31 Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997 0.96
32 Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus. Transplant Proc 1969 0.96
33 Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993 0.92
34 A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry. Clin Diagn Lab Immunol 1997 0.92
35 A competitive reverse transcription-polymerase chain reaction assay for quantitation of GB virus C/hepatitis G virus RNA that circumvents heteroduplex artifact. J Virol Methods 1999 0.91
36 Human rheumatoid factor crossidiotypes. II. Primary structure-dependent crossreactive idiotype, PSL2-CRI, present on Wa monoclonal rheumatoid factors is present on Bla and other IgM kappa monoclonal autoantibodies. J Exp Med 1987 0.90
37 Complement-human histocompatibility antigen haplotypes in C2 deficiency. J Clin Invest 1981 0.89
38 Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum 1978 0.88
39 Two distinct abnormalities in patients with C8 alpha-gamma deficiency. Low level of C8 beta chain and presence of dysfunctional C8 alpha-gamma subunit. J Clin Invest 1990 0.88
40 Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology 1982 0.85
41 The epidemiology of migraine: a retrospective study in Italian emergency departments. Headache 1998 0.84
42 Evidence for detection of low molecular weight DNA--anti-DNA complexes in systemic lupus erythematosus. Arthritis Rheum 1982 0.84
43 Detection of immune complexes. J Invest Dermatol 1976 0.84
44 Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement. J Rheumatol 1983 0.84
45 Selective depression of the C4 component of complement: evidence for an association with genetic deficiency of C4 and dermatologic diseases. Diagn Immunol 1983 0.84
46 Characterization of complement-fixing activity and cross-idiotypes of rheumatoid factors in idiopathic mixed cryoglobulinemia. Clin Immunol Immunopathol 1983 0.83
47 Therapy for cryoglobulinemia secondary to hepatitis C virus: the need for tailored protocols and multiclinic studies. J Rheumatol 2000 0.80
48 Hereditary C2 deficiency: association with skin lesions resembling the discoid lesion of systemic lupus erythematosus. Arthritis Rheum 1976 0.80
49 Hereditary C2 deficiency in systemic lupus erythematosus and acquired complement abnormalities in an unusual SLE-related syndrome. Birth Defects Orig Artic Ser 1975 0.79
50 Immune complexes in hepatitis C. Hepatology 1997 0.78
51 The immunopathogenesis of lupus nephritis. Adv Nephrol Necker Hosp 1976 0.78
52 Lymphocytic hypophysitis in a man. J Clin Endocrinol Metab 1987 0.78
53 OCCURRENCE OF gamma-GLOBULIN COMPLEXES IN SERUM AND JOINT FLUID OF RHEUMATOID ARTHRITIS PATIENTS: USE OF MONOCLONAL RHEUMATOID FACTORS AS REAGENTS FOR THEIR DEMONSTRATION. J Exp Med 1971 0.78
54 Immune complex assays in rheumatic diseases. Hum Pathol 1983 0.77
55 Partial genetic deficiency of the C4 component of complement in discoid lupus erythematosus and urticaria/angioedema. J Am Acad Dermatol 1983 0.77
56 Myths, misconceptions and mixed cryoglobulinemia associated with HCV infection. Minerva Gastroenterol Dietol 2002 0.77
57 WA monoclonal rheumatoid factors and non-Hodgkin lymphoma. Blood 2001 0.75
58 Interferon alfa-2a for cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994 0.75
59 Eradication of hepatitis C virus after interferon-alpha therapy. Ann Intern Med 1995 0.75
60 [Clinico-statistical studies of 334 cases of leukemia in childhood]. Minerva Pediatr 1980 0.75
61 Congenital deficiency of C2 and factor B. N Engl J Med 1978 0.75
62 Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia. Clin Immunol Immunopathol 1987 0.75
63 Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia. Arthritis Rheum 1999 0.75
64 [Evaluation of the therapeutic efficacy and tolerance of a new aminoglycoside antibiotic, sisomicin in urinary tract infections of the upper and lower urinary tract]. Minerva Urol 1979 0.75
65 [Statural growth in children with acute lymphoblastic leukemia]. Minerva Pediatr 1982 0.75
66 Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from viruslike particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994 0.75